Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.
China-based endoscopy technology developer Scivita Medical Technology has pulled in nearly RMB400m ($61.7m) through a series A round backed by pharmaceutical firm Eli Lilly and medical device maker Medtronic.
Eli Lilly corporate venturing vehicle Lilly Asia Ventures and GL Ventures, a venture capital fund owned by hedge fund manager Hillhouse Capital, co-led the round, which also featured Matrix Partners China, Chengwei Capital and Shanghai Innochip Investment Company.
Scivita Medical is developing medical devices used by healthcare professionals to inspect the…
